Survey of Canadian Physician Use of Botulinum Toxin A (BoNT-A) for Paratonia: Real World Insights.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2025 Vol.52(1) p. 141-144

Kleiner G, Ismail F, Khan O, Pilieci C, Truong L, Boulias C

관련 도메인

Abstract

Paratonia is a form of hypertonia characterized by an inability to relax muscles in the setting of cognitive impairment. Paratonia results in pain, refusal of care, and caregiver burden. We sent surveys to 67 Canadian physiatrists and neurologists regarding their experience treating paratonia with botulinum toxin A (BoNT-A). Twenty-seven survey respondents were included in the analysis. Thirteen percent of survey respondents treating paratonia with BoNT-A reported a significant clinically relevant improvement; 74% endorsed a moderately clinically relevant improvement; 13% endorsed a slight clinically relevant improvement. Ninety percent of survey respondents endorsed significant barriers in treating paratonia with BoNT-A.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 2
해부 muscles scispacy 1
약물 botulinum toxin A C0006050
botulinum toxin type A
scispacy 1
약물 BoNT-A → Botulinum Toxin A scispacy 1
질환 hypertonia C0026826
Muscle Hypertonia
scispacy 1
질환 cognitive impairment C0338656
Impaired cognition
scispacy 1
질환 pain C0030193
Pain
scispacy 1
질환 paratonia C0231519
Gegenhalten
scispacy 1
기타 Botulinum Toxin A scispacy 1
기타 BoNT-A → Botulinum Toxin A scispacy 1

MeSH Terms

Humans; Canada; Botulinum Toxins, Type A; Neuromuscular Agents; Muscle Hypertonia; Surveys and Questionnaires; Physicians; Female; Male; Neurologists; Practice Patterns, Physicians'; Physiatrists

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문